每年秋冬，气温转凉，呼吸道合胞病毒（RSV）便开始肆虐，成为人们健康的一大威胁。尤其是婴幼儿、老年人以及免疫力低下者，一旦感染 RSV，可能引发如毛细支气管炎、肺炎等严重疾病，甚至危及生命。据相关数据显示，在婴幼儿呼吸道感染病例中，RSV 感染占比居高不下，是导致婴幼儿因下呼吸道感染住院的首要病因 。对于 60 岁以上的老年人，感染 RSV 后住院风险和重症风险也显著增加 。 不过现在有个好消息！

Abrysvo has the potential to become the first and only RSV vaccine for adults 18 years and older. Participants demonstrated RSV-A and RSV-B subgroup-neutralizing responses that were non-inferior to ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...

GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.

As Pfizer races to grow the respiratory syncytial virus (RSV) vaccine market along with rival GSK, the company has been looking to expand its vaccine's reach. Now, armed with fresh data for Abrysvo in ...

First assessment from an RSV vaccine study in immunocompromised adults show ABRYSVO was well-tolerated and generated strong neutralizing responses after a single dose in adults ≥ 18 years of age These ...

(RTTNews) - The U.S. Food and Drug Administration announced the approval of Pfizer Inc.'s Abrysvo (Respiratory Syncytial Virus Vaccine) for use in pregnant individuals to prevent respiratory syncytial ...

(RTTNews) - The European Commission approved Pfizer Inc.'s (PFE) Abrysvo to help protect infants through maternal immunization and older adults from respiratory syncytial virus or RSV. It is the first ...

(RTTNews) - Pfizer Inc. (PFE) announced that the U.S. Food and Drug Administration approved ABRYSVO (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F or RSVpreF vaccine, ...

The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo has been approved as a maternal vaccine to ...